HealthMap

Open on a desktop browser to explore the interactive map. The knowledge graph needs a larger screen and a pointer. On this device you are limited to the text below.

Dr. Ronald Roth Acu-Cell AI

Galantamine Therapy for Alzheimer's

Classification and Mechanism: Galantamine is a reversible, competitive acetylcholinesterase inhibitor that also acts as an allosteric modulator of nicotinic acetylcholine receptors.
Approved Indication: It is officially indicated and widely used for the treatment of mild to moderate Alzheimer's disease.
Therapeutic Goal: The primary objective of using galantamine in these stages is to temporarily stabilize or slow the decline of cognitive, global, and behavioral functions by increasing acetylcholine concentrations in the central nervous system.
Biochemical and Nutritional Considerations:
Optimal neurological function heavily relies on adequate status of foundational cofactors, particularly B-complex vitamins (such as B12, folate, and B6) and essential minerals, which support overall neuronal metabolism.
Cellular membrane integrity and neurotransmitter synthesis are heavily dependent on proper lipid and antioxidant balance to help mitigate oxidative stress commonly associated with neurodegeneration.
Clinical Monitoring: Treatment efficacy and patient tolerance should be regularly evaluated, keeping in mind potential gastrointestinal and cardiovascular side effects typical of cholinesterase inhibition.

AI-generated in the approach of Dr. Ronald Roth. Not his own words.

Traversing graph…

Connections

Galantamine - connections

Galantamine ->

Is A: Cholinesterase inhibitors

Alzheimer's disease - connections

Alzheimer's disease ->

Affects: Selenium (Aspect: intake)
Causes: Agitation, Apathy, Confusion, Depression, Fear of nonexistent things, Memory loss, Movement problems, Perception problems, Speech problems (Frequency: generally)
Depletes: Sulfur (Progression: proportional; Terminal: unmeasurable)
Diagnosed By Excluding: Dementias (Frequency: usually; Scope: other types)
Has Form: Early-onset Alzheimer's disease, Late-onset Alzheimer's disease
Has Level: Sulfur (Level: deficient; Degree: very)
Has Level: Selenium (Level: low; Degree: very; Frequency: not always)
Is A: Dementias
Named After: Dr. Alois Alzheimer
Occurs As: Early-onset Alzheimer's disease (Sex distribution: almost equally in men and women)
Requires Increase Of: Sulfur supplements
Requires Increase Of: Eggs, Garlic, Onions (Richness: sulfur_rich)

-> Alzheimer's disease

Dietary sulfur, Supplemental sulfur - Adjusted For (Recommendation: should; Manner: accordingly)
Selenium - Associated With (Level: below normal; Location: intracellular)
Sulfur levels - Associated With (Level: not measurable; Stage: late; Population: every patient tested)
Sulfur levels - Associated With (Level: significantly below normal; Stage: early; Population: every patient tested)
Sulfur levels - Associated With (Level: totally deficient; Stage: late; Population: every patient tested)
Selenium, Sulfur - Associated With (Level: very low; Location: intracellular)
Vitamin B6, B12 and folic acid combination - Benefits (Polarity: negative; Evidence: another study; Population: Alzheimer's patients)
Sulfur-raising therapy - Benefits (Response: positive; Observer: Dr. Ronald Roth; Degree: inversely proportional to disease progression)
Amyloid infection, Prion infection - Causes
Glutamate - Causes (Concentration: elevated; Location: extracellular; Certainty: thought)
Intracellular copper - Causes (Level: high; Partner: sulfur deficiency)
Neurotransmitters - Causes (State: lack; Certainty: thought)
Acetylcholine deficiency - Component Of (Importance: key)
Glutamate-rich food sources - Concerns (Certainty: believed; Agent: some researchers)
Aluminum - Contributes To (Certainty: maintained; Significance: significant)
Dementias - Due To (Proportion: up to 70%)
Antibiotics - Halts (Certainty: may; Condition: if it should happen; Aspect: progression)
Drugs - Halts (Quantity: some; Certainty: may; Condition: if it should happen; Aspect: progression)
Dr. Alois Alzheimer - Identified (Year: 1906)
Advanced glycation end products - Implicated In (Domain: dietary)
Omega-3 essential fatty acids, Vitamin A, Vitamin C, Vitamin E - Implicated In (State: deficiency; Certainty: possible; Domain: nutritional)
APOE gene mutation, Alcohol abuse, Apolipoprotein E-4, Depression, Free radical damage, Head trauma, Parkinson's disease - Increases Risk Of
Electromagnetic exposure - Increases Risk Of (Duration: long-term)
Brain shrinkage - Increases Risk Of (Importance: major)
Family history of Alzheimer's disease - Increases Risk Of (Predisposition: inherited; Proportion: 5-10%)
Mental stimulation - Increases Risk Of (State: lack)
Herpes simplex - Initiates (Certainty: believed; Evidence: one case)
Late-onset Alzheimer's disease - Is A (Frequency: most common; Onset: age 60 or older)
Early-onset Alzheimer's disease - Is A (Onset: before age 60)
Sulfur supplementation - Prevents (Certainty: potential)
Aluminum, Copper, Iron, Manganese, Zinc - Promotes (Exposure: above normal)
High-copper, low-sulfur status - Promotes (Mechanism: biochemical platform)
Vitamin D - Protects Against (Certainty: under study; Effect: neuroprotective; Goal: slow progression)
Sulfur supplementation - Reverses (Certainty: potential; Condition: not progressed to substantial brain damage)
Coconut oil - Reverses (Evidence: one case; Publicity: heavy; Mechanism: antimicrobial effect; Condition: believed herpes simplex-initiated development)
Antibiotics - Slows (Certainty: under study; Aspect: progression)
Drugs - Slows (Quantity: some; Certainty: may; Aspect: progression)
Cholinesterase inhibitors - Treats
Tacrine - Treats (Frequency: not much; Timing: any longer; Reason: potential liver damage)
MSM - Treats (Stage: early or moderate; Importance: major turning point; Relation: low sulfur)

Sulfur-raising therapy - connections

Sulfur-raising therapy ->

Benefits: Alzheimer's disease (Response: positive; Observer: Dr. Ronald Roth; Degree: inversely proportional to disease progression)

-> Sulfur-raising therapy

Dr. Ronald Roth - Observed (Population: Alzheimer's disease patients)

Is galantamine used in mild to moderate Alzheimer therapy? Which environmental metal buildup is implicated in Alzheimer's disease? Is Alzheimer disease more prevalent in females than males? Which symptom indicates low sulfur status in Alzheimer's patients? Does MSM supplementation help normalize low cellular sulfur? Is vascular dementia distinct from Alzheimer's disease? How do sulfur levels in ALS compare to Alzheimer's disease? Does high copper intake promote memory loss in Alzheimer's? Can low cellular sulfur status contribute to Alzheimer's disease? What mineral deficiency is characteristic in Alzheimer's patients? Is selenium deficient in mid-stage Alzheimer's patients? What neurotransmitter is targeted by memantine therapy? What nutrient zinc depletion occurs during chronic steroid use? What effect does gene therapy have on micro dystrophin delivery? What cobalt isotope Cobalt-60 is used in radiation therapy? Does radiation therapy carry an up to 80 percent failure rate? Can physical therapy maintain joint mobility in MD patients? Can cold laser therapy benefit localized tissue inflammation? Does H pylori triple therapy combine PPI and two antibiotics? Can potassium supplementation prevent muscle cramps on steroids?

Overview

Loading graph...

Display TOP 100%

Loading full knowledge graph…

Building graph…

Preparing…

Filter by Relationship

Filter by Type

Some information may be incomplete, disputed, or incorrect. Review the supporting sources.